相关实验视频

Updated: Jun 14, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K

HSF1是肝脏内胆管癌的预后决定因素和治疗标

Antonio Cigliano1,2, Isabella Gigante3, Marina Serra2,4

  • 1Department of Medicine, Surgery, and Pharmacy, University of Sassari, via P. Manzella 4, Sassari, 07100, Italy.

Journal of experimental & clinical cancer research : CR
|September 6, 2024
PubMed
概括

热冲击因子1 (HSF1) 在肝内胆管癌 (iCCA) 中升高调节,并与预后不佳有关. 抑制HSF1通过减少iCCA细胞增殖和诱导亡,显示出治疗潜力.

关键词:
在HSF1中.在肝脏内发生的胆管癌,胆管癌.在KRIBB-11中使用.鼠标模型 鼠标模型在Navitoclaxx上使用.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

2.2K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K